drugset / Trial / NCT01523574

Vitamin E for Oxaliplatin-induced Peripheral Neuropathy Prophylaxis

NCT01523574 ↗

Phase 2 Completed 38 enrolled Felipe Melo Cruz
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Introduction: Oxaliplatin (Ox) is a frequently used platinum-based medication that is a part of many chemotherapy regimens for the treatment of several gastrointestinal malignancies. One of the most important limitations to its use is the induction of both acute and chronic peripheral neuropathy (PN). Previous studies have shown that vitamin E can reduce the incidence of cisplatin-induced PN by 50%. In this study, the investigators aimed to determine if vitamin E could also prevent Ox-induced acute PN

Timeline

Start
2009-08
Primary completion
2010-11
Completion
2010-12

Outcome

Missed primary endpoint

paper CONCLUSIONS No significant decrease in the incidence of acute oxaliplatin-induced peripheral neuropathy was demonstrated through vitamin E use. PMID 23538593 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin E Other / unclassified 400 mg Oral

Indications